The programme is listed below. The majority of the speakers have generously allowed us to make their presentations available for download. To request access to this area of the site please email us stating your name, organisation and reason for access.
|
Time |
Event |
Speaker |
|
09.15 - 10.10 |
Functional Complement - C1 Esterase Inhibitor |
|
|
Assay anomalies |
Alice Wiltshire |
| 09.40 – 10.00 |
Clinical utility |
Bob Lock |
|
10.00 – 10.10 |
Review of EQA data |
Peter White |
|
10.10 – 10.45 |
Alpha 1 Antitryspin Phenotyping |
|
10.10 – 10.30 |
Methodology unravelled |
Graeme Wild |
|
10.30 – 10.45 |
Progress with the pilot EQA Schemes |
Dina Patel |
|
10.45 – 11.15 |
TEA |
|
11.15 – 11.45 |
Specific Microbial Antibodies |
|
11.15 – 11.45 |
EQA of Pneumococcal antibody serotype specific assays |
Daniel Harrison |
|
11.45 – 12.45 |
Antibodies ot Citrullinated Proteins |
|
11.45 – 12.00 |
Review of EQA data |
Dina Patel |
|
12.00 – 12.45 |
Utility of the assays and requesting strategy in clinical practice |
Gerry Wilson |
|
12.45 – 14.00 |
LUNCH |
|
14.00 – 15.30 |
Tumour Markers |
|
14.00 – 14.50 |
Clinical and analytical aspects of the CA markers |
Kristina Hotakainen |
|
14.50 – 15.15 |
CA19-9 - a laboratory perspective |
Ian Barlow |
|
15.15 – 15.30 |
Summary and discussion |
Peter White |
|
15.30 – 16.00 |
TEA |
|
16.00 – 18.00 |
Clinical Workshops
C1 Autoimmune endocrine (Prof. Steve Nussey)
C2 Autoimmune rheumatic (Dr. Anderew Keat)
C3 B cell malignancy (Dr. John Parker Williams)
C4 Skin diseases (Dr. Bob Sarkany)
C5 Immune deficiency (Dr. Bridget Heelan)
C6 Renal disease (Dr. Ian McPhee)
C7 Respiratory disease and allergy (Dr. Sarah Deacock)
C8 Neurological diseases (Dr. Michael Lunn)
C9 Gut and liver diseases (Dr. Ron Zeegen)
|
|
Evening |
DINNER |
UK NEQAS participants' Meeting